Science & Research
MAQC Working Groups
The MAQC project involves six FDA Centers, major providers of microarray platforms and RNA samples, National Institutes of Health (NIH), Environmental Protection Agency (EPA), National Institute of Standards and Technology (NIST), academic laboratories, and other stakeholders.
Working Group | Coordinator (Organization) | Responsibilities |
---|---|---|
CWG (Clinical) |
| Nomination and selection of clinical microarray data sets for MAQC-II |
TGxWG (Toxicogenomics) |
| Nomination and selection of toxicogenomics microarray data sets for MAQC-II |
Titration WG (Titration) |
| Coordination of the analysis of MAQC titration data sets from mixing samples A and B |
RBWG (Regulatory Biostatistics) |
| Coordination of statistical issues and review of data analysis protocols within MAQC-II |
GWAWG (Genome-Wide Association) |
| Coordination of genome-wide association data analysis within MAQC-II |
CNVWG (Copy Number Variation) |
| Coordination of genome-wide copy number variation analysis within MAQC-II |
MAQC |
| Coordination of the entire MAQC project |
Contact Information
Please address questions and suggestions about the MicroArray Quality Control project to Dr. Leming Shi at Leming.Shi@fda.hhs.gov or Dr. Weida Tong at Weida.Tong@fda.hhs.gov or Reagan Kelly at Reagan.Kelly@fda.hhs.gov.
Contact FDA
Food and Drug Administration
3900 NCTR Road
Jefferson, AR 72079